c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
| 281.1 | J05AB | brivudin | p.o. | 0.5 | GM | 458,88 | P |
|
| 281.2 | J05AB01 | acyklovir do 200 mg včetně | p.o. | 4 | GM | 272,00 | P |
| 57068 | ACICLOVIRAL 200 | tbl 25x200mg | APA | D |
| 84127 | HERPESIN 200 | tbl 25x200mg | PVL | CZ |
| 54031 | PROVIRSAN | tbl 30x200mg | PMP | CZ |
| 54213 | RANVIR 200 | tbl 25x200mg | RXG | IND |
| 53608 | XOROX 200MG | tbl 25x200mg | KWI | A |
| 281.3 | J05AB01 | acyklovir nad 200 mg | p.o. | 4 | GM | 225,30 | P |
| 56079 | ACICLOVIR AL 400 | tbl 35x400mg | APA | D |
| 54216 | RANVIR 400 | tbl 25x400mg | RXG | IND |
| 53610 | XOROX 400MG | tbl 60x400mg | KWI | A |
| 53611 | XOROX 800MG | tbl 35x800mg | KWI | A |
| 281.4 | J05AB04 | ribavirin | p.o. | 1 | GM | 604,96 | X |
| 58274 | REBETOL 200 MG | por cpsdur168x200mg | SCH | B |
| 281.5 | J05AB06 | gancyklovir | p.o. | 3 | GM | 1960,07 | P |
| 59653 | CYMEVENE 250 MG | por cpsdur84x250mg | RPE | GB |
| 281.6 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 458,88 | P |
|
| 281.7 | J05AB11 | valacyklovir | p.o. | 3 | GM | 374,00 | P |
|
| 281.8 | J05AB14 | valgancyklovir | p.o. | 0,9 | GM | 2000,00 | P |
| 97249 | VALCYTE 450 MG | por tbl flm60x450mg | HLR | D |
| 281.9 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 453,70 | P |
| 59463 | FORTOVASE 200 MG | cps 180x200mg | HLR | D |
| 281.10 | J05AE02 | indinavir | p.o. | 2,4 | GM | 453,70 | P |
|
| 281.11 | J05AE03 | ritonavir | p.o. | 1,2 | GM | 453,70 | P |
| 02940 | NORVIR | cps 2x84=168x100mg | ABB | GB |
| 281.12 | J05AE04 | nelfinavir | p.o. | 2,25 | GM | 453,70 | P |
|
| 281.13 | J05AE | inhibitory proteáz (lopinavir,ritonavir v kombinaci) | p.o. | 6 | DF | 564,00 | P |
|
| 281.14 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
|
| 281.15 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
|
| 281.16 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 235,25 | P |
| 66733 | HIVID 0.375 MG | tblobd100x0.375mg-b | HLR | CH |
| 66734 | HIVID 0.75 MG | tblobd100x0.75mg-b | HLR | CH |
| 281.17 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 53209 | ZERIT 40 MG | cps 56x40mg | BMS | F |
| 281.18 | J05AF05 | lamivudin do 100 mg v jedné tabletě včetně respektive do 5 mg v jednom mililitru včetně | p.o. | 0,3 | GM | 292,03 | P |
| 02085 | ZEFFIX 100 MG | tbl obd 28x100mg | GOW | GB |
| 02086 | ZEFFIX 100 MG | tbl obd 84x100mg | GOW | GB |
| 02087 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWL | GB |
| 94802 | ZEFFIX 5MG/ML | sol 1x240ml/1.2g | GWE | D |
| 281.19 | J05AF05 | lamivudin nad 100 mg v jedné tabletě respektive nad 5 mg v jednom mililitru | p.o. | 0,3 | GM | 248,01 | P |
|
| 281.20 | J05AF06 | abacavir | p.o. | 600 | MG | 360,00 | P |
|
| 281.21 | J05AF30 | abacavir, lamivudin a zidovudin v kombinaci | p.o. | 2 | DF | 852,04 | P |
| 30158 | TRIZIVIR | por tbl flm 60 | GOW | GB |
| 281.22 | J05AF30 | jiné kombinace antiretrovirových virostatik (lamivudin a zidovudin) | p.o. | 2 | DF | 522,13 | P |
|
| 281.23 | J05AG01 | nevirapin | p.o. | 0,4 | GM | 343,34 | P |
|
| 281.24 | J05AG03 | efavirenz | p.o. | 0,6 | GM | 431,00 | P |
|
| 281.25 | J05AH01 | zanamivir | inhal. | 20 | MG | 130,00 | P |